Evidence map›Paper›PMID 29782882›Full record

ArticleNeurotoxicology2018

Prolonged increase in ser31 tyrosine hydroxylase phosphorylation in substantia nigra following cessation of chronic methamphetamine.

Michael F Salvatore, Vicki A Nejtek, Habibeh Khoshbouei

Open access · greenAbstract read
In one paragraph

Article in Neurotoxicology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Michael F SalvatoreInstitute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, United States; Department of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, LA, United States. Electronic address: Michael.Salvatore@unthsc.edu.
Vicki A NejtekInstitute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, United States.
Habibeh KhoshboueiDepartment of Neuroscience, University of Florida, Gainesville, FL, United States; Center for Addiction Research & Education, University of Florida, Gainesville, FL, United States.
Louisiana State University Health Sciences Center Shreveport · USUniversity of Florida · USUniversity of North Texas Health Science Center · US

Funding

Alpha-synuclein Regulates Dopamine Transporter FunctionsR01NS071122 · NINDS · UNIVERSITY OF FLORIDA · PI KHOSHBOUEI, HABIBEH · 2010 to 2022
$3.9M
Methamphetamine regulates the dopamine transporter via an intracellular mechanismR01DA026947 · NIDA · UNIVERSITY OF FLORIDA · PI KHOSHBOUEI, HABIBEH · 2010 to 2019
$3.5M
Targeting nigral tyrosine hydroxylase to improve locomotion in agingR01AG040261 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI SALVATORE, MICHAEL F · 2012 to 2015
$1.1M
NIA NIH HHS R01 AG040261NIDA NIH HHS R01 DA026947NINDS NIH HHS R01 NS071122
6 · The paper itself

Abstract

Methamphetamine (MA) exposure may increase the risk of motor or cognitive impairments similar to Parkinson's disease (PD) by middle age. Although damage to nigrostriatal or mesoaccumbens dopamine (DA) neurons may occur during or early after MA exposure, overt PD-like symptoms at a younger age may not manifest due to compensatory mechanisms to maintain DA neurotransmission. One possible compensatory mechanism is increased tyrosine hydroxylase (TH) phosphorylation. In the rodent PD 6-OHDA model, nigrostriatal lesion decreases TH protein in both striatum and substantia nigra (SN). However, DA loss in the SN is significantly less than that in the striatum. An increase in ser31 TH phosphorylation in the SN may increase TH activity in response to TH loss. To determine if similar compensatory mechanisms may be engaged in young mice after MA exposure, TH expression, phosphorylation, and DA tissue content were evaluated, along with dopamine transporter expression, 21 days after cessation of MA (24 mg/kg, daily, 14 days). DA tissue content was unaffected by the MA regimen in striatum, nucleus accumbens, SN, or ventral tegmental area (VTA), despite decreased TH protein in SN and VTA. In the SN, but not striatum, ser31 phosphorylation increased over 2-fold. This suggests that increased ser31 TH phosphorylation may be an inherent compensatory mechanism to attenuate DA loss against TH loss, similar to that in an established PD model. These results also indicate the somatodendritic compartments of DA neurons are more vulnerable to TH protein loss than terminal fields following MA exposure.

Indexed as

AnimalsDopamineDopamine Uptake InhibitorsDose-Response Relationship, DrugDrug Administration ScheduleMaleMethamphetamineMiceMice, Inbred C57BLPhosphorylationRandom AllocationSerineSubstantia NigraTime FactorsTyrosine 3-MonooxygenaseDopamineDopamine Uptake InhibitorsMethamphetamineSerineTyrosine 3-MonooxygenaseAgingDopamine transporterMethamphetamineParkinson’s diseasePhosphorylationTyrosine hydroxylase

Identifiers

PMID29782882
PMCPMC6088751
OpenAlexW2804581155

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.